The Patent Finder
SB

Senti Biosciences, Inc.

First filing 2019
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Five patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2038. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2038
Next term end
5
Patent families

When these terms end

Each bar runs from grant to computed term end. 2022 to 2043.
US 11,446,332 Combinatorial Cancer Immunotherapy Apr 13, 2038
US 11,419,898 Combinatorial Cancer Immunotherapy Oct 17, 2039
US 12,005,081 Chimeric Receptors and Methods of Use Thereof May 10, 2040
US 12,653,839 Protein Payload Release Nov 29, 2042
US 12,611,458 Chimeric Receptors and Methods of Use Thereof May 9, 2043
202620302034203820422043
30 pending applications: term is not computable until grant.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Patents held now

Soonest term end first.

Showing 1 to 5 of 5

PatentTitleStatusExpiresConfidence
US 11,446,332Combinatorial Cancer Immunotherapy
In force
 · High confidence
In forceHigh confidence
US 11,419,898Combinatorial Cancer Immunotherapy
In force
 · High confidence
In forceHigh confidence
US 12,005,081Chimeric Receptors and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 12,653,839Protein Payload Release
In force
 · Medium confidence
In forceMedium confidence
US 12,611,458Chimeric Receptors and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 5: 1 patent ended · 30 applications pending · 14 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited